GVR Report cover Embolic Protection Devices Market Size, Share & Trends Report

Embolic Protection Devices Market Size, Share & Trends Analysis Report By Product (Distal Occlusion Devices, Proximal Occlusion Devices, Distal Filters), By Application, By Region, And Segment Forecasts, 2024 - 2030

  • Report ID: GVR-2-68038-483-3
  • Number of Report Pages: 80
  • Format: PDF, Horizon Databook
  • Historical Range: 2018 - 2022
  • Forecast Period: 2024 - 2030 
  • Industry: Healthcare

Embolic Protection Devices Market Trends

The global embolic protection devices market size was valued at USD 612.9 million in 2023 and is projected to grow at a CAGR of 8.7% from 2024 to 2030. Growing number of patients suffering from cardiovascular and neurovascular disorders is fueling the market growth. The rise in minimally invasive procedures due to the shorter recovery time and less complications compared to traditional surgical methods is driving the market growth.

Embolic Protection Devices Market Size by Product, 2020 - 2030 (USD Million)

Embolic protection devices are useful in reducing the complications in procedures such as angioplasty. These devices reduce the chances of debris entering the bloodstream and causing blockages in smaller vessels during cardiac procedures. This is expected to boost the demand for embolic protection devices in the coming years.

Product Insights & Trends

Distal filters accounted for the largest share of 49.7% in 2023 due to their ability to offer efficient protection against embolization during interventional procedures. These devices are designed to block the vessel at the end, preventing debris from moving downstream and leading to possible blockages. Moreover, distal occlusion devices provide improved navigability and traceability, allowing accurate placement and removal. The growing demand for less invasive procedures and the rising incidences of cardiovascular diseases are fueling the penetration of distal occlusion devices.

Distal occlusion devices are projected to witness a CAGR of 8.9% over the forecast period. Distal occlusion devices act as a barrier, catching debris such as blood clots, plaque, or other particles that may break loose during interventions, therefore reducing the chance of embolization and related issues.

Application Insights & Trends

Cardiovascular diseases dominated the market with a share of 47.8% in 2023 due to the rising prevalence of cardiovascular diseases such as peripheral arterial disease and coronary artery disease. The ongoing research and development efforts to improve the performance of these devices are also leading to segment growth.

Embolic Protection Devices Market Share by Application, 2023 (%)

Neurovascular diseases are projected to grow at a CAGR of 7.9% over the forecast period. The increasing prevalence of neurovascular disorders such as ischemic aneurysms, stroke, and arteriovenous malformations has led to an increased demand for effective treatment options. Moreover, technological advancements have improved the design and safety of these devices, resulting in increased reliability for patients. The growing awareness among healthcare professionals about the advantages of using embolic protection devices in neurovascular procedures has led to an increase in their usage.

Regional Insights & Trends

North America embolic protection devices market held 43.9% of the market share in 2023. It is expected to grow rapidly in the coming years due to the high adoption rate of newly developed products, increasing obesity and presence of prominent manufacturers in the region.

Embolic Protection Devices Market Trends, by Region, 2024 - 2030

U.S. Embolic Protection Devices Market Trends

The U.S. dominated the North American embolic protection devices market with a share of 77.5% in 2023. It is attributed to the rising incidences of neurovascular and cardiovascular diseases and growing demand for technologically advanced products. According to U.S. Centers for Disease Control and Prevention, every year about 805,00 people suffer from heart attack and coronary heart disease is the most common heart disease that led to the death of 375,476 people in 2021.

Europe Embolic Protection Devices Market Trends

Europe embolic protection devices market was identified as a lucrative region in 2023 due to advanced healthcare facilities in the region According to the European Society of Cardiology, cardiovascular diseases are responsible for the majority of deaths in Europe, accounting for almost 45% of all deaths.

The UK embolic protection devices market is expected to grow rapidly in the coming years due to the rising incidences of cardiovascular diseases due to unhealthy dietary practices & lifestyle choices, favorable reimbursement policies and increasing healthcare expenditure in the country.

The Germany embolic protection devices market held a substantial market share in 2023. This is due to the strong healthcare infrastructure and renowned expertise in medical research and development.

Asia Pacific Embolic Protection Devices Market Trends

Asia Pacific is anticipated to witness significant growth in the coming years owing to the improving healthcare infrastructure, easy access to healthcare services, increasing incidences of cardiovascular diseases, and growing elderly population.

The significant market share of embolic protection devices in China in 2023 can be attributed to the country’s large population base and rising incidences of cardiovascular diseases.

The India embolic protection devices market held a substantial share due to several factors including India’s expanding healthcare infrastructure and growing population.

Key Embolic Protection Devices Company Insights 

Some of the key companies in the embolic protection devices market include Boston Scientific Corporation, Edwards Lifesciences Corporation, Abbott, Medtronic and others. Vendors in the market are focusing on increasing their customer base to gain a competitive edge in the industry. 

  • Edwards Lifesciences Corporation specializes in manufacturing and development of devices for structural heart diseases and critical care monitoring.

Key Embolic Protection Devices Companies:

The following are the leading companies in the embolic protection devices market. These companies collectively hold the largest market share and dictate industry trends.

  • Boston Scientific Corporation
  • Edwards Lifesciences Corporation.
  • Abbott.
  • Medtronic
  • Cardinal Health.
  • Innovative Cardiovascular Solutions, LLC
  • Transverse Medical, Inc.
  • W. L. Gore & Associates, Inc.

Recent Developments

  • In April 2024, Emboline, Inc., announced the acquisition of SWAT Medical’s Intellectual Property Portfolio of embolic protection. This acquisition is expected to expand Emboline’s existing portfolio of platform technologies to reduce the risk of stroke caused due to the release of embolic debris in the bloodstream during procedures such as Transcatheter Aortic Valve Replacement (TAVR). 

Embolic Protection Devices Market Report Scope

Report Attribute

Details

Market size value in 2024

USD 658.1 million

Revenue forecast in 2030

USD 1.09 billion

Growth Rate

CAGR of 8.7% from 2024 to 2030

Base year for estimation

2023

Historical data

2018 - 2022

Forecast period

2024 - 2030

Report updated

August 2024

Quantitative units

Revenue in USD billion and CAGR from 2024 to 2030

Report coverage

Revenue forecast, company ranking, competitive landscape, growth factors, and trends

Segments covered

Product, application, region

Regional scope

North America, Europe, Asia Pacific, Latin America, MEA

Country scope

U.S., Canada, Mexico, UK, Germany, France, Italy, Spain, Denmark, Sweden, Norway, Japan, China, India, Australia, Thailand, South Korea, Brazil, Mexico, Colombia, Argentina, South Africa, Saudi Arabia, UAE, Kuwait

Key companies profiled

Boston Scientific Corporation ; Edwards Lifesciences Corporation.; Abbott.; Medtronic ; Cardinal Health.; Innovative Cardiovascular Solutions, LLC; Transverse Medical, Inc.; W. L. Gore & Associates, Inc.

Customization scope

Free report customization (equivalent up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.

Pricing and purchase options

Avail customized purchase options to meet your exact research needs. Explore purchase options

Global Embolic Protection Devices Market Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global embolic protection devices market report based on product, application, and region.

Embolic Protection Devices Market Report Segmentation

  • Product Outlook (Revenue, USD Million, 2018 - 2030)

    • Distal Occlusion Devices

    • Proximal Occlusion Devices

    • Distal Filters

  • Application Outlook (Revenue, USD Million, 2018 - 2030)

    • Cardiovascular Diseases

    • Neurovascular Diseases

    • Peripheral Vascular Diseases

  • Regional Outlook (Revenue, USD Million, 2018 - 2030)

    • North America

      • U.S.

      • Mexico

      • Canada

    • Europe

      • UK

      • Germany

      • France

      • Italy

      • Spain

      • Denmark

      • Sweden

      • Norway

    • Asia Pacific

      • Japan

      • China

      • India

      • South Korea

      • Thailand

      • Australia

    • Latin America

      • Brazil

      • Argentina

    • MEA

      • South Africa

      • Saudi Arabia

      • UAE

      • Kuwait

pdf icn

GET A FREE SAMPLE

arrow icn

This FREE sample includes data points, ranging from trend analyses to estimates and forecasts. See for yourself.

gvr icn

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities. Contact us now

Certified Icon

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.